enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Lifileucel - Wikipedia

    en.wikipedia.org/wiki/Lifileucel

    Lifileucel is the first tumor-derived T cell immunotherapy approved by the US Food and Drug Administration (FDA). [3] It was approved for medical use in the United States in February 2024. [ 2 ] [ 4 ]

  3. Sulopenem/probenecid - Wikipedia

    en.wikipedia.org/wiki/Sulopenem/probenecid

    Trial 2 (NCT03354598) was a noninferiority trial in which 1660 adult women with uncomplicated urinary tract infections were randomized and treated. [2] Sulopenem/probenecid demonstrated efficacy in participants with ciprofloxacin-resistant pathogens with a composite response rate of 48% compared to a composite response rate of 33% in the ...

  4. Fingolimod - Wikipedia

    en.wikipedia.org/wiki/Fingolimod

    Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. [4] Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.

  5. Ocrelizumab - Wikipedia

    en.wikipedia.org/wiki/Ocrelizumab

    In February 2016, the US Food and Drug Administration (FDA) granted breakthrough therapy designation for primary progressive multiple sclerosis. [21] In March 2017, the FDA approved ocrelizumab for relapsing-remitting and primary-progressive multiple sclerosis. It is the first FDA-approved treatment for the primary progressive form.

  6. FDA approves Eli Lilly’s obesity medication for obstructive ...

    www.aol.com/news/fda-approves-eli-lilly-obesity...

    The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity -- the first medication ...

  7. Immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Immunotherapy

    The use of monoclonal antibodies in cancer therapy was first introduced in 1997 with rituximab, an anti-CD20 antibody for treatment of B cell lymphoma. [15] Since then several monoclonal antibodies have been approved for treatment of various haematological malignancies as well as for solid tumours. [16] [17]

  8. The FDA Just Approved Opill, the First Over-the-Counter Birth ...

    www.aol.com/lifestyle/fda-just-approved-opill...

    The FDA approved the first over-the-counter birth control pill—Opill—in a landmark feat. ... Perrigo submitted “years of research to FDA to show that women could understand and follow ...

  9. A busy longevity clinic owner is 33 but says her biological ...

    www.aol.com/busy-longevity-clinic-owner-33...

    She said she has also hired female Ph.D. candidates to "dive into the literature" around women's health and longevity to inform her female-focused protocols, which she sells as part of a ...